Cargando…

Development and Validation of a Risk Score for Febrile Neutropenia After Chemotherapy in Patients With Cancer: The FENCE Score

BACKGROUND: Febrile neutropenia (FN) after chemotherapy causes a high burden of morbidity and mortality. We aimed to develop and validate a risk score to predict FN in the first cycle of chemotherapy. METHODS: We included patients with solid cancers and diffuse large B-cell lymphomas at Rigshospital...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aagaard, Theis, Roen, Ashley, Reekie, Joanne, Daugaard, Gedske, Brown, Peter de Nully, Specht, Lena, Sengeløv, Henrik, Mocroft, Amanda, Lundgren, Jens, Helleberg, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649794/ https://www.ncbi.nlm.nih.gov/pubmed/31360873 http://dx.doi.org/10.1093/jncics/pky053

Ejemplares similares

1549. Development and Validation of a Cycle-Specific Risk Score for Febrile Neutropenia After Chemotherapy in Patients with Cancer: The (CSR)FENCE Score
por: Aagaard, Theis, et al.
Publicado: (2018)

Mortality and admission to intensive care units after febrile neutropenia in patients with cancer
por: Aagaard, Theis, et al.
Publicado: (2020)

Prediction of Febrile Neutropenia after Chemotherapy Based on Pretreatment Risk Factors among Cancer Patients
por: Aagaard, Theis, et al.
Publicado: (2017)

Febrile Neutropenia and Long-term Risk of Infection Among Patients Treated With Chemotherapy for Malignant Diseases
por: Nordvig, Josefine, et al.
Publicado: (2018)

252. Increased incidence rates of positive blood cultures shortly after chemotherapy treatment initiation among individuals treated for solid malignant tumours
por: Roen, Ashley O, et al.
Publicado: (2020)

Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours
por: Roen, Ashley, et al.
Publicado: (2022)

2613. The Epidemiology of Respiratory Syncytial Virus (RSV) in People with Immune Dysfunction Seen at a Tertiary Hospital Between 2010 and 2017
por: Li, Qiuju, et al.
Publicado: (2019)

Validation of the (CSR)FENCE score for prediction of febrile neutropenia during chemotherapy cycles 2–6
por: Zatarah, Razan, et al.
Publicado: (2022)

1075. Absolute Lymphocyte Count as a Predictor of Cytomegalovirus (CMV) Infection and Recurrence in Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Reekie, Joanne, et al.
Publicado: (2020)

2569. The Gut Microbiome and Acute Graft vs. Host Disease Risk in Hematopoietic Stem Cell Transplantation Recipients
por: Ilett, Emma E, et al.
Publicado: (2019)

Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
por: Ilett, Emma E, et al.
Publicado: (2019)

Validation of the FENCE Risk Groups for Prediction of Febrile Neutropenia With First-Cycle Chemotherapy
por: Zatarah, Razan, et al.
Publicado: (2022)

The reliability of FEbrile Neutropenia after ChEmotherapy (FENCE) scores in predicting granulocyte colony-stimulating factor breakthrough febrile neutropenia among patients with lymphoma undergoing first-cycle chemotherapy: A prospective observational study
por: Thungthong, Pravinwan, et al.
Publicado: (2023)

Gut microbiome comparability of fresh-frozen versus stabilized-frozen samples from hospitalized patients using 16S rRNA gene and shotgun metagenomic sequencing
por: Ilett, Emma E., et al.
Publicado: (2019)

Chest x-ray imaging score is associated with severity of COVID-19 pneumonia: the MBrixia score
por: Jensen, Christian M., et al.
Publicado: (2022)

23. Development and Validation of a Risk Score for Post-transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients
por: dos Santos, Quenia, et al.
Publicado: (2021)

Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients
por: dos Santos, Quenia, et al.
Publicado: (2022)

Association between Breast Cancer Polygenic Risk Score and Chemotherapy-Induced Febrile Neutropenia: Null Results
por: Ong, Seeu Si, et al.
Publicado: (2022)

Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study
por: Bhardwaj, Prarthna V., et al.
Publicado: (2021)

Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?
por: Ono, Yoshitaka, et al.
Publicado: (2022)

1079. The Risk of Cytomegalovirus (CMV) Infection and Recurrence Among Solid Organ Transplant Recipients
por: Reekie, Joanne, et al.
Publicado: (2020)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Febrile Neutropenia in Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2018)

Febrile Neutropenia in Children with Cancer
por: Paulus, Stéphane, et al.
Publicado: (2008)

Coronaviruses in children with febrile neutropenia
por: Alvares, Paula A., et al.
Publicado: (2013)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)

Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Management of chemotherapy-associated febrile neutropenia
por: Cameron, D
Publicado: (2009)

Clozapine-Induced Febrile Neutropenia and Cellulitis
por: YAYLACI, Selcuk, et al.
Publicado: (2016)

Timely Assessment and Management of Febrile Neutropenia
por: Viale, Pamela Hallquist
Publicado: (2019)

Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009)

How I Treat Febrile Neutropenia
por: Nucci, Marcio
Publicado: (2021)

Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
por: Monuszko, Karen A., et al.
Publicado: (2021)

Prevention of febrile neutropenia: use of prophylactic antibiotics
por: Cullen, M, et al.
Publicado: (2009)

Impact of effective prevention and management of febrile neutropenia
por: Krell, D, et al.
Publicado: (2009)

Outpatient management of febrile neutropenia in children with cancer
por: Ziino, Ottavio, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5paerq7rq9o929mq88gbl5egb5